Epidemiological and clinical characteristics of patients with antimicrobial resistant isolates by country of birth (n=2183), Euro-GASP 2010–2014
| Epidemiological and clinical characteristics | Country of birth | P value | P value* | ||
| Native no. (%) | Foreign-born no. (%) | ||||
| Year of diagnosis (n=2183) | 2010 | 225 (12.4) | 31 (8.5) | 0.02 | 0.04 |
| 2011 | 383 (21.1) | 66 (18.0) | 0.2 | ||
| 2012 | 393 (21.6) | 99 (27.0) | 0.02 | ||
| 2013 | 443 (24.4) | 84 (23.0) | 0.59 | ||
| 2014 | 373 (20.5) | 86 (23.5) | 0.2 | ||
| Age (years) (n=2165) | <25 | 459 (25.5) | 96 (26.3) | <0.01 | 0.79 |
| 25–44 | 1033 (57.4) | 231 (63.3) | 0.04 | ||
| ≥45 | 308 (17.1) | 38 (10.4) | <0.01 | ||
| Sexual orientation (n=1737) | Heterosexual females | 169 (12.1) | 29 (8.5) | 0.14 | – |
| Heterosexual males | 637 (45.7) | 158 (46.2) | – | ||
| Men who have sex with men | 589 (42.2) | 155 (45.3) | – | ||
| Isolation site (n=2127) | Anorectal | 195 (11.0) | 66 (18.4) | <0.01 | <0.01 |
| Urogenital | 1484 (83.9) | 268 (74.7) | <0.01 | ||
| Pharyngeal | 89 (5.0) | 25 (7.0) | 0.15 | ||
| HIV status (n=1396) | Positive | 144 (12.7) | 42 (15.8) | 0.19 | – |
| Negative | 987 (87.3) | 223 (84.2) | – | ||
| Previous gonorrhoea (n=1478) | Yes | 181 (14.7) | 31 (12.8) | 0.48 | – |
| No | 1054 (85.3) | 212 (87.2) | – | ||
| Probable country of infection (n=1328) | Reporting country | 1081 (94.3) | 162 (89.0) | <0.01 | – |
| Other country | 65 (5.7) | 20 (11.0) | – | ||
*Calculated only for those variables with more than two categories and p value <0.05.
Euro-GASP, European Gonococcal Antimicrobial Surveillance Programme.